GERMANY – BioNTech and Medigene have formed a multi-target research collaboration to develop T-cell receptor (TCR)-based immunotherapies for cancer treatment. The partnership will be for three years in its initial…
Read MoreBioNTech and Medigene team up to develop cancer immunotherapies
